129 related articles for article (PubMed ID: 8956976)
1. Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin.
Benoit NE; Wade WF
Immunopharmacology; 1996 Nov; 35(2):129-39. PubMed ID: 8956976
[TBL] [Abstract][Full Text] [Related]
2. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
3. Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas.
Funakoshi S; Longo DL; Murphy WJ
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):93-101. PubMed ID: 8732692
[TBL] [Abstract][Full Text] [Related]
4. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells.
Hokazono Y; Adachi T; Wabl M; Tada N; Amagasa T; Tsubata T
J Immunol; 2003 Aug; 171(4):1835-43. PubMed ID: 12902484
[TBL] [Abstract][Full Text] [Related]
6. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.
Plumas J; Jacob MC; Chaperot L; Molens JP; Sotto JJ; Bensa JC
Blood; 1998 Apr; 91(8):2875-85. PubMed ID: 9531598
[TBL] [Abstract][Full Text] [Related]
7. Ligation of CD40 with soluble CD40 ligand reverses anti-immunoglobulin-mediated negative signalling in murine B lymphoma cell lines but not in immature B cells from neonatal mice.
Marshall-Clarke S; Owen G; Tasker L
Immunology; 1996 Apr; 87(4):624-32. PubMed ID: 8675219
[TBL] [Abstract][Full Text] [Related]
8. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.
Uckun FM; Gajl-Peczalska K; Myers DE; Jaszcz W; Haissig S; Ledbetter JA
Blood; 1990 Dec; 76(12):2449-56. PubMed ID: 1702326
[TBL] [Abstract][Full Text] [Related]
9. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype.
Galibert L; Burdin N; de Saint-Vis B; Garrone P; Van Kooten C; Banchereau J; Rousset F
J Exp Med; 1996 Jan; 183(1):77-85. PubMed ID: 8551247
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation.
Xerri L; Bouabdallah R; Devilard E; Hassoun J; Stoppa AM; Birg F
Br J Cancer; 1998 Jul; 78(2):225-32. PubMed ID: 9683298
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes.
Murphy WJ; Funakoshi S; Beckwith M; Rushing SE; Conley DK; Armitage RJ; Fanslow WC; Rager HC; Taub DD; Ruscetti FW
Blood; 1995 Sep; 86(5):1946-53. PubMed ID: 7544649
[TBL] [Abstract][Full Text] [Related]
12. Binding to CD20 by anti-B1 antibody or F(ab')(2) is sufficient for induction of apoptosis in B-cell lines.
Cardarelli PM; Quinn M; Buckman D; Fang Y; Colcher D; King DJ; Bebbington C; Yarranton G
Cancer Immunol Immunother; 2002 Mar; 51(1):15-24. PubMed ID: 11845256
[TBL] [Abstract][Full Text] [Related]
13. CM1 ligation initiates apoptosis in a caspase 8-dependent manner in Ramos cells and in a mitochondria-controlled manner in Raji cells.
Kim D; Hur DY; Kim YS; Lee K; Lee Y; Cho D; Kang JS; Kim YI; Hahm E; Yang Y; Yoon S; Kim S; Lee WB; Park HY; Kim YB; Hwang YI; Chang KY; Lee WJ
Hum Immunol; 2002 Jul; 63(7):576-87. PubMed ID: 12072193
[TBL] [Abstract][Full Text] [Related]
14. High CD40 membrane expression in AIDS-related lymphoma B cell lines is associated with the CD45RA+, CD45RO+, CD95+ phenotype and high levels of its soluble form in culture supernatants.
De Paoli P; Cozzi M; Tedeschi R; Gloghini A; Cilia AM; van Kooten C; Gaidano G; Carbone A
Cytometry; 1997 Feb; 30(1):33-8. PubMed ID: 9056740
[TBL] [Abstract][Full Text] [Related]
15. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
16. Effect of B-cell receptor engagement on CD40-stimulated B cells.
Schilizzi BM; Boonstra R; The TH; de Leij LF
Immunology; 1997 Nov; 92(3):346-53. PubMed ID: 9486107
[TBL] [Abstract][Full Text] [Related]
17. Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells.
Shan D; Ledbetter JA; Press OW
Cancer Immunol Immunother; 2000 Mar; 48(12):673-83. PubMed ID: 10752475
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of CD40 in human bladder carcinoma cells inhibits anti-Fas/APO-1 (CD95)-induced apoptosis.
Jakobson E; Jönsson G; Björck P; Paulie S
Int J Cancer; 1998 Sep; 77(6):849-53. PubMed ID: 9714053
[TBL] [Abstract][Full Text] [Related]
19. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4.
Rigley KP; Callard RE
Eur J Immunol; 1991 Mar; 21(3):535-40. PubMed ID: 1707000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]